Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Merck
Express Scripts
Farmers Insurance
Novartis
Federal Trade Commission
Cerilliant
Cipla
Citi
Teva

Generated: February 23, 2018

DrugPatentWatch Database Preview

E-GLADES Drug Profile

« Back to Dashboard

When do E-glades patents expire, and what generic alternatives are available?

E-glades is a drug marketed by Mylan Pharms Inc and is included in one NDA.

The generic ingredient in E-GLADES is erythromycin. There are one hundred and one drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for E-GLADES
Drug patent expirations by year for E-GLADES
Medical Subject Heading (MeSH) Categories for E-GLADES

US Patents and Regulatory Information for E-GLADES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc E-GLADES erythromycin GEL;TOPICAL 065009-001 Mar 18, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
US Department of Justice
Chubb
Citi
Daiichi Sankyo
Cipla
Cantor Fitzgerald
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot